ISee3D Announces $500,000 Financing Commitment
Friday, 20 April 2012 08:00 PM
Vancouver, April 20, 2012 - ISee3D Inc. (TSXV: ICT) ("ISee3D" or the "Company") is pleased to announce that it has entered into a financing commitment with an existing shareholder (the "Lender") for a $500,000 credit facility (the "Credit Facility"). Under the terms of the Credit Facility, the Lender will provide funding to ISee3D in the form of a line of credit, which may be drawn down in tranches by the Company as required.
The Credit Facility is for a term of 6 months with interest payable monthly at a rate equal to 6% per annum. The Credit Facility and all other liabilities of the Company owing to the Lender (including $1,500,000 of previously issued promissory notes) will be secured by a first priority general security agreement over all of the assets of the Company.
The commitment to provide the Credit Facility is subject to the satisfaction of certain conditions precedent, including the execution of agreed credit and security documentation, on or before April 27, 2012.
The Credit Facility will be used to fund a strategic review of the Company's operating plan, pursue potential joint venture and merger possibilities and for general working capital purposes.
Corporate Contact:
Terry Debono
Chairman and Chief Executive Officer
ISee3D Inc,
Forward-looking Statement
This news release contains certain forward-looking statements and information within the meaning of applicable securities laws, which reflect current expectations of the management of the Company regarding future events or the Company's future performance, including, without limitation, statements relating to the timing and/or initiation of clinical trials, clinical trial results, the introduction of new products, associated regulatory clearances, economic or financial trends or expectations, financing, acceptance of the Company's products in the marketplace and the hiring or retention of personnel. Forward-looking statements are often, but not always, identified by the use of words such as "expect", "anticipate", "seek", "aim", "continue", "estimate", "objective", "ongoing", "may", "will", "would", "project", "predict", "potential", "could", "should", "might", "believe", "plan", "target", "intend" and similar expressions. All statements other than statements of historical fact contained in this news release may be forward-looking statements. The forward-looking information included in this document does not guarantee future performance and should not be unduly relied upon. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information, including, without limitation, the impact of competition, consumer confidence and spending levels, general economic conditions, interest and currency exchange rates, unseasonable weather patterns, the cost and availability of capital and grants/funding, product development uncertainties, labour market challenges and consumer acceptance of new products. The Company believes that the expectations and assumptions reflected in the forward-looking information contained herein are reasonable but no assurance can be given that these expectations and assumptions are correct or that that the results, performance or achievements expressed in, or implied by, forward-looking statements herein will occur, or if they do, that any benefits may be derived from them. The Company can give no assurance that new product development initiatives will lead to new product commercialization, in this case as it relates to medical science imaging. The Company assumes no duty to update or revise forward looking information, except as may be required pursuant to applicable laws. All forward-looking information is expressly qualified in its entirety by this cautionary statement. Further information regarding risks and uncertainties relating to the Company and its securities can be found in the disclosure documents filed by the Company with the securities regulatory authorities, available at www.sedar.com.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWS
